Home › Overweight › New York
Overweight clinical trials in New York
44 studies for Overweight are looking for participants at sites in New York.
Cities in New York
- New York City19 studies
- Rochester13 studies
- Buffalo7 studies
- Manhattan4 studies
- Syracuse4 studies
- Brooklyn3 studies
- The Bronx3 studies
Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity
- Equity Medical, LLC, The Bronx
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07830329Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Rochester Clinical Research, Rochester
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 9, 2026 · NCT07871409A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Rochester Clinical Research, Buffalo
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351045Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- NYC Research Inc, New York
- Rochester Clinical Research, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07685808Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Icahn School of Medicine at Mount Sinai, New York
- Rochester Clinical Research, Rochester
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 6, 2026 · NCT07575399A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- Rochester Clinical Research, Inc, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07843498A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Drug Trials America, Hartsdale
- NYC Research INC, Long Island City
- Rochester Clinical Research, LLC, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Weill Cornell Medicine - Comprehensive Weight Control Center, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- NYC Research, New York
- IMA Clinical Research NYC Midtown, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Equity Medical, New York
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06857942A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NYC Research INC, Long Island City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- NYU Langone Health, New York
- Weill Cornell Medical College, New York
- IMA Clinical Research Manhattan, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Ellipsis Research Group - Brooklyn - 7th Street, Brooklyn
- Rochester Clinical Research - Buffalo, Buffalo
- NYC Research INC, Long Island City
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- New York Gastroenterology Associates, New York
- Care Access - Yonkers, Yonkers
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Rochester Clinical Research - Buffalo, Buffalo
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
- Care Access - Yonkers, Yonkers
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937086A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- UBMD Pediatrics, Buffalo
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Nov 4, 2026 · NCT06672549A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- NYC Research INC, Long Island City
- Richmond University Medical Center, Staten Island
- Southgate Medical Group, West Seneca
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT06897475A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Cortland
- Research Site, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07784725Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Rochester Clinical Research /ID# 282484, Rochester
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- ALSA Research-Manhattan, New York
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 26, 2026 · NCT07837973A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Albany
- ACCOMPLISH-2 Research Site, Albany
- ACCOMPLISH-2 Research Site, Brooklyn
- and 1 more
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Oct 20, 2026 · NCT07654374Effects of Ultra Processed Food on Intestinal Energy Harvest
- Columbia University Irving Medical Center, New York
Recruiting
Ages 25 and older · All sexes · Updated Oct 9, 2026 · NCT06853288A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Dent Neurologic Institute, Amherst
- Rochester Clinical Research, LLC, Rochester
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 8, 2026 · NCT07589608A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Dent Neurologic Institute, Amherst
- Velocity Clinical Research, Syracuse, East Syracuse
- Rochester Clinical Research, LLC, Rochester
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 7, 2026 · NCT06143956AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Weil Cornell Medicine, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT07571109Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Velocity Clinical Research- Binghamton, Binghamton
- Rochester Clinical Research, Rochester
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 5, 2026 · NCT07684235Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
- State University of New York at Buffalo, South Campus, Buffalo
Recruiting
Ages 18 to 60 · All sexes · Updated Oct 2, 2026 · NCT07641361Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
- Weill Cornell -1300 York Avenue, New York
- Lenox Hill Hospital | Northwell Health, New York
Recruiting
Ages 21 to 65 · All sexes · Updated Oct 1, 2026 · NCT07090005A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- UBMD Physicians Group - Pediatrics - Conventus, Buffalo
- SUNY Upstate Medical Univ - Syracuse, Syracuse
- Advantage Clinical Trials, The Bronx
RecruitingPhase 3
Ages 8 to 18 · All sexes · Updated Sep 30, 2026 · NCT07253285AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Comprehensive Weight Ctrl Prog, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Ichor Research, Syracuse
- Southgate Medical Group, LLP, West Seneca
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07668414A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Rochester Clinical Research, LLC, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07321886A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, East Northport
- AURORA-2 Clinical Site, East Syracuse
- AURORA-2 Clinical Site, New Windsor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, New Windsor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Weil Cornell Medicine, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07571005Alpelisib Challenge Test (ACT)
- Columbia University Irving Medical Center, New York
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07778524Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
- Mexican Consulate's Ventanilla de Salud (VDS), New York
RecruitingPhase 2Healthy volunteers welcome
Ages 21 and older · All sexes · Updated Sep 2, 2026 · NCT05770570Human Models of Selective Insulin Resistance: Alpelisib, Part I
- Columbia University Irving Medical Center, New York
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Aug 24, 2026 · NCT06354088AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- NYU Langone Orthopedic Center, New York
- Hospital For Special Surgery, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07509307From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.